Shorting few stocks which is breaking yesterday low and below Super trend 10.2 and also few stock with DC 50 low broken.
More from Trendmyfriend
bhai, I don't know what will nifty doing next but I am ready👇
Stock below 10.2 first time after big run - Pelo
Stock hit dc 50 low first time - Pelo
Stock getting rejection from 10.2- Lelo
Stock getting hit dc 50 high- Lelo
fresh maal milega, n move will be sharp n rewarding👍
Stock below 10.2 first time after big run - Pelo
Stock hit dc 50 low first time - Pelo
Stock getting rejection from 10.2- Lelo
Stock getting hit dc 50 high- Lelo
fresh maal milega, n move will be sharp n rewarding👍
On which side, if I may ask
— Surjeet Singh (@er_surjeet25) October 28, 2021
Do not short any stock which is trading near 52 week or life high ( at least 8-10%).
It will just take 1 day to clear the high again.
Make it simple rule Do not short stock till its trading 10% near 52 week or life high.
It will just take 1 day to clear the high again.
Make it simple rule Do not short stock till its trading 10% near 52 week or life high.
#Divis
— Anand Luhar (@anand_luhar) June 10, 2021
Thank you soo much All shorter of #Divis
apke bena aye gain possible he nahi tha
\U0001f64f\U0001f64f\U0001f64f pic.twitter.com/CanXrMwlP9
You May Also Like
@EricTopol @NBA @StephenKissler @yhgrad B.1.1.7 reveals clearly that SARS-CoV-2 is reverting to its original pre-outbreak condition, i.e. adapted to transgenic hACE2 mice (either Baric's BALB/c ones or others used at WIV labs during chimeric bat coronavirus experiments aimed at developing a pan betacoronavirus vaccine)
@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2
@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj
@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o
@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz
@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj

@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o
